ANN ARBOR, Mich., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that it has been granted usage rights to a significant block of government-owned mulberry gardens located near its spider silk production operations in Southeast Asia.
These land-use rights, granted to Kraig Labs by a key government agency as part of the Company’s collaborative relationship, will play a central role in Kraig Labs' ongoing production expansion. The Company has agreed to pay a nominal rent for the use of the mulberry gardens. These mulberry gardens will provide the essential feedstock required to support the scaled-up of recombinant spider silk production. This added capacity will directly support the manufacturing of high-performance spider silk yarns targeted at performance textiles, technical apparel, and luxury fashion markets.
The newly secured acreage will provide a reliable and strategically positioned source of high-quality mulberry leaf, an essential input for maintaining production throughput and improved logistics. This alignment between land access, production capacity, and downstream processing is a key component of Kraig Labs' strategic expansion blueprint.
Today's announcement follows closely on the Company's recently announced order from a leading performance sports apparel brand. Kraig Labs is currently finalizing materials for this customer's pilot development program, which will utilize the Company's recombinant spider silk fibers. The addition of these mulberry gardens strengthens Kraig Labs' ability to meet future commercial demand as it advances toward broader market deployments.
"Access to these mulberry gardens marks another critical step in building an integrated and resilient production ecosystem for our spider silk technologies," said Kim Thompson, Founder and CEO of Kraig Biocraft Laboratories. "Securing direct access to high-quality mulberry acreage gives us greater control over our supply chain and positions us to accelerate production of our BAM-1 Alpha hybrid spider silk. This collaboration with government stakeholders reflects their confidence in the economic and technological potential of our work."
As this land is transferred to Kraig Labs' control, the Company will prepare the gardens for incorporation into its expanding spider silk production pipeline. Additional staffing and operational resources will be deployed as part of the integration process, supporting both near-term production increases and the Company's strategic vision for large-scale commercialization.
For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.
For details about other recent Kraig Labs advancements, please watch the Company's investor conference at www.kraiglabs.com/videos or on the Company's YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
* For a description of our historical leadership in this technology, please follow this link https://www.kraiglabs.com/world-leader/
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, Inc.
(720) 288-8495
